UBS Group’s Semler Scientific SMLR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-65,576
| Closed | -$1M | – | 11111 |
|
|
2025
Q4 | $1M | Sell |
65,576
-23,617
| -26% | -$536K | ﹤0.01% | 5572 |
|
|
2025
Q3 | $2.68M | Buy |
89,193
+17,112
| +24% | +$589K | ﹤0.01% | 4688 |
|
|
2025
Q2 | $2.79M | Buy |
72,081
+20,048
| +39% | +$715K | ﹤0.01% | 4462 |
|
|
2025
Q1 | $1.88M | Sell |
52,033
-67,774
| -57% | -$3.18M | ﹤0.01% | 4754 |
|
|
2024
Q4 | $6.47M | Buy |
119,807
+115,481
| +2,669% | +$5.31M | ﹤0.01% | 3537 |
|
|
2024
Q3 | $102K | Buy |
4,326
+2,690
| +164% | +$77.3K | ﹤0.01% | 6350 |
|
|
2024
Q2 | $56.3K | Sell |
1,636
-7,081
| -81% | -$204K | ﹤0.01% | 6606 |
|
|
2024
Q1 | $255K | Buy |
8,717
+1,395
| +19% | +$58.2K | ﹤0.01% | 5685 |
|
|
2023
Q4 | $324K | Buy |
7,322
+4,823
| +193% | +$173K | ﹤0.01% | 5442 |
|
|
2023
Q3 | $63.4K | Sell |
2,499
-757
| -23% | -$19.7K | ﹤0.01% | 6138 |
|
|
2023
Q2 | $85.4K | Buy |
3,256
+2,955
| +982% | +$77.9K | ﹤0.01% | 6139 |
|
|
2023
Q1 | $8.07K | Buy |
301
+201
| +201% | +$5.63K | ﹤0.01% | 7757 |
|
|
2022
Q4 | $3.3K | Sell |
100
-2,174
| -96% | -$75.4K | ﹤0.01% | 9530 |
|
|
2022
Q3 | $85K | Buy |
2,274
+2,045
| +893% | +$77.2K | ﹤0.01% | 5852 |
|
|
2022
Q2 | $6K | Buy |
+229
| New | +$8.19K | ﹤0.01% | 8717 |
|
|
2016
Q3 | – | Sell |
-1,290
| Closed | -$2K | – | 7909 |
|
|
2016
Q2 | $2K | Buy |
1,290
+714
| +124% | +$1.25K | ﹤0.01% | 7447 |
|
|
2016
Q1 | $1K | Buy |
576
+175
| +44% | +$374 | ﹤0.01% | 7455 |
|
|
2015
Q4 | $1K | Sell |
401
-1,252
| -76% | -$3.51K | ﹤0.01% | 8175 |
|
|
2015
Q3 | $4K | Buy |
1,653
+494
| +43% | +$1.52K | ﹤0.01% | 7839 |
|
|
2015
Q2 | $4K | Sell |
1,159
-751
| -39% | -$2.65K | ﹤0.01% | 7989 |
|
|
2015
Q1 | $7K | Buy |
1,910
+784
| +70% | +$3.12K | ﹤0.01% | 7919 |
|
|
2014
Q4 | $2K | Buy |
+1,126
| New | +$2.71K | ﹤0.01% | 9421 |
|
UBS Group's SMLR Position: Q1 2026 in Review
UBS Group sold out of Semler Scientific (SMLR) in Q1 2026, closing a stake of 65,576 shares — an estimated $1M sold.
UBS Group first reported a position in SMLR in Q4 2014 and held it in 22 quarters. The position peaked at $6.47M in Q4 2024. 0 funds tracked by Wall St. Rank hold SMLR as of Q1 2026.
- UBS Group reported no remaining Semler Scientific position as of Q1 2026 after selling out during the quarter.
- UBS Group sold 65,576 Semler Scientific shares in Q1 2026, an estimated $1M.
- UBS Group first reported a position in Semler Scientific in Q4 2014 and held it in 22 quarters.
- UBS Group's Semler Scientific position peaked at $6.47M in Q4 2024.
- 0 funds tracked by Wall St. Rank held Semler Scientific as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.